Since the establishment of the European Medical Evaluation Agency (EMEA; London) in 1995, 127 new chemical entities/biotechnology products have been approved for human use 4, of which 44 (34% ...

Products were studied mainly in five therapeutic ... demonstrating the growth potential of the rDNA market (the core sector of the medical biotech sector) over the next 6 years, focusing on ...

AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...

The official made the remarks on Tuesday, addressing the 4th International Conference and Exhibition on Iranian Medical Biotech Products and Related Industries (Iran Bio) being held from February 4 to ...

and engineering to develop new products and technologies for a variety of industries. It encompasses a wide range of applications, including genetic engineering, medical biotechnology ...